Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Millward

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2005
Detection of unsuspected spinal cord compression in melanoma patients by 18F-fluorodeoxyglucose-positron emission tomographyA B Francken, A M Hong, M J Fulham, et al.
Radiation Oncology Investigations|January 1, 1997
Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft modelM A Joschko, L K Webster, J Groves, et al.
Gynecologic Oncology|October 1, 1996
Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxelJ D Shapiro, M J Millward, D Rischin, et al.
British Journal of Cancer|April 1, 1992
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancerM J Lind, B M Cantwell, M J Millward, et al.
British Journal of Haematology|April 1, 1996
Association of acquired Pelger-Huet anomaly with taxoid therapyS K Juneja, J P Matthews, R Luzinat, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2001
Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancerM J Boyer, P Mitchell, D Goldstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibioticsD Rischin, S P Ackland, J Smith, et al.
Australian and New Zealand Journal of Medicine|February 1, 1997
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancerJ D Shapiro, M J Millward, D Rischin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patientsM J Millward, M J Boyer, M Lehnert, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 9, 2005
Detection of unsuspected spinal cord compression in melanoma patients by 18F-fluorodeoxyglucose-positron emission tomographyA B Francken, A M Hong, M J Fulham, et al.
Radiation Oncology Investigations|January 1, 1997
Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft modelM A Joschko, L K Webster, J Groves, et al.
Gynecologic Oncology|October 1, 1996
Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxelJ D Shapiro, M J Millward, D Rischin, et al.
British Journal of Cancer|April 1, 1992
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancerM J Lind, B M Cantwell, M J Millward, et al.
British Journal of Haematology|April 1, 1996
Association of acquired Pelger-Huet anomaly with taxoid therapyS K Juneja, J P Matthews, R Luzinat, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2001
Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancerM J Boyer, P Mitchell, D Goldstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibioticsD Rischin, S P Ackland, J Smith, et al.
Australian and New Zealand Journal of Medicine|February 1, 1997
Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancerJ D Shapiro, M J Millward, D Rischin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patientsM J Millward, M J Boyer, M Lehnert, et al.
Pageof 6